GWM
IRMD icon

Geneos Wealth Management’s iRadimed IRMD Stock Holding History

Geneos Wealth Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-66
Closed -$3.95K – 2829
2025
Q2 		$3.95K Sell
66
-138
-68% -$7.56K ﹤0.01% 2638
2025
Q1 		$10.7K Buy
204
+182
+827% +$10.2K ﹤0.01% 2549
2024
Q4 		$1.21K Hold
22
– – ﹤0.01% 2730
2024
Q3 		$1.11K Buy
+22
New +$1.01K ﹤0.01% 2427

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geneos Wealth Management's IRMD Position: Q3 2025 in Review

Geneos Wealth Management sold out of iRadimed (IRMD) in Q3 2025, closing a stake of 66 shares — an estimated $3.95K sold.

Geneos Wealth Management first reported a position in IRMD in Q3 2024 and held it in 4 quarters. The position peaked at $10.7K in Q1 2025. 185 funds tracked by Wall St. Rank hold IRMD as of Q3 2025.

  • Geneos Wealth Management reported no remaining iRadimed position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 66 iRadimed shares in Q3 2025, an estimated $3.95K.
  • Geneos Wealth Management first reported a position in iRadimed in Q3 2024 and held it in 4 quarters.
  • Geneos Wealth Management's iRadimed position peaked at $10.7K in Q1 2025.
  • 185 funds tracked by Wall St. Rank held iRadimed as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.